Shares of Chewy, Inc. (NYSE:CHWY – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-one analysts that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and twelve have issued a buy rating on the company. The average 12-month target price among brokers that have covered the stock in the last year is $29.11.
CHWY has been the topic of a number of research analyst reports. UBS Group boosted their target price on Chewy from $21.00 to $30.00 and gave the stock a “neutral” rating in a research note on Thursday, August 29th. Argus downgraded Chewy from a “buy” rating to a “hold” rating in a research note on Tuesday, July 9th. Morgan Stanley upped their price objective on Chewy from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Monday, August 26th. Bank of America upped their price objective on Chewy from $20.00 to $24.00 and gave the company an “underperform” rating in a research note on Thursday, August 29th. Finally, Robert W. Baird upped their price objective on Chewy from $26.00 to $32.00 and gave the company an “outperform” rating in a research note on Tuesday, August 20th.
Get Our Latest Stock Report on CHWY
Insider Transactions at Chewy
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. EntryPoint Capital LLC increased its stake in Chewy by 18.0% in the first quarter. EntryPoint Capital LLC now owns 4,066 shares of the company’s stock valued at $65,000 after acquiring an additional 619 shares during the last quarter. B. Riley Wealth Advisors Inc. increased its stake in Chewy by 3.2% in the first quarter. B. Riley Wealth Advisors Inc. now owns 28,359 shares of the company’s stock valued at $451,000 after acquiring an additional 870 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its position in Chewy by 10.0% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,325 shares of the company’s stock valued at $308,000 after buying an additional 1,029 shares during the period. 1620 Investment Advisors Inc. purchased a new stake in Chewy during the second quarter valued at about $33,000. Finally, Camelot Portfolios LLC boosted its position in Chewy by 14.0% during the first quarter. Camelot Portfolios LLC now owns 10,200 shares of the company’s stock valued at $162,000 after buying an additional 1,249 shares during the period. Institutional investors own 93.09% of the company’s stock.
Chewy Stock Up 0.2 %
Shares of NYSE CHWY opened at $29.36 on Friday. Chewy has a twelve month low of $14.69 and a twelve month high of $39.10. The stock’s 50 day moving average price is $27.10 and its 200-day moving average price is $22.49. The company has a market capitalization of $12.77 billion, a PE ratio of 163.11, a PEG ratio of 2.98 and a beta of 1.04.
Chewy (NYSE:CHWY – Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.02. Chewy had a return on equity of 21.00% and a net margin of 3.20%. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.86 billion. As a group, research analysts expect that Chewy will post 0.32 EPS for the current fiscal year.
Chewy Company Profile
Chewy, Inc, together with its subsidiaries, engages in the pure play e-commerce business in the United States. It provides pet food and treats, pet supplies and pet medications, and other pet-health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its retail websites and mobile applications.
Further Reading
- Five stocks we like better than Chewy
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Manufacturing Stocks Investing
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Roth IRA Calculator: Calculate Your Potential Returns
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Chewy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chewy and related companies with MarketBeat.com's FREE daily email newsletter.